Evidence for Selective Transformation of Autoreactive Immature Plasma Cells in Mice Deficient in Fasl
暂无分享,去创建一个
M. Shin | D. Roopenian | H. Morse | T. Torrey | C. Okumura | T. McCarty | Z. Naghashfar | W. Davidson | M. Hori | J. Zhou | C. Lee | P. Mukhopadhyay | J. Zhang | Jian Zhang
[1] Takeshi Suzuki,et al. High-Throughput Retroviral Tagging for Identification of Genes Involved in Initiation and Progression of Mouse Splenic Marginal Zone Lymphomas , 2004, Cancer Research.
[2] H. Xin,et al. Interleukin-6 Induces Expression of Ifi202, an Interferon-inducible Candidate Gene for Lupus Susceptibility* , 2004, Journal of Biological Chemistry.
[3] E. Schattner,et al. Lymphoma B Cells Evade Apoptosis through the TNF Family Members BAFF/BLyS and APRIL. , 2004, The Journal of Immunology.
[4] K. Tarte,et al. BAFF and APRIL protect myeloma cells from apoptosis induced by IL-6 deprivation and dexamethasone , 2003 .
[5] B. Harder,et al. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. , 2004, Blood.
[6] R. Bende,et al. Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. , 2003, Cancer research.
[7] K. Tarte,et al. Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation. , 2003, Blood.
[8] S. Levy,et al. Hepatitis C Virus (HCV) and Lymphomagenesis , 2003, Leukemia & lymphoma.
[9] H. Groux,et al. The complex role of interleukin-10 in autoimmunity. , 2003, Journal of autoimmunity.
[10] Gregory H Underhill,et al. Gene expression profiling reveals a highly specialized genetic program of plasma cells. , 2003, Blood.
[11] N. Kakazu,et al. Constitutive Expression of AID Leads to Tumorigenesis , 2003, The Journal of experimental medicine.
[12] W. Klapper,et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. , 2003, Blood.
[13] Chad W. Euler,et al. Activation of Rheumatoid Factor (RF) B Cells and Somatic Hypermutation Outside of Germinal Centers in Autoimmune‐Prone MRL/lpr Mice , 2003, Annals of the New York Academy of Sciences.
[14] Chen-feng Qi,et al. B lymphoid neoplasms of mice: characteristics of naturally occurring and engineered diseases and relationships to human disorders. , 2003, Advances in immunology.
[15] Reuben S Harris,et al. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. , 2002, Molecular cell.
[16] M. Teitell,et al. PKC-β controls IκB kinase lipid raft recruitment and activation in response to BCR signaling , 2002, Nature Immunology.
[17] M. Monestier,et al. Receptor Revision and Systemic Lupus , 2002, Scandinavian journal of immunology.
[18] A. Carbone,et al. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus‐associated non‐Hodgkins's lymphomas , 2002, European journal of immunology.
[19] M. Du,et al. Mucosa-associated lymphoid tissue lymphoma , 2002, Current opinion in hematology.
[20] M. Teitell,et al. PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. , 2002, Nature immunology.
[21] A. Feeney,et al. Unusual Germline DSP2 Gene Accounts for All Apparent V-D-D-J Rearrangements in Newborn, But Not Adult, MRL Mice1 , 2001, The Journal of Immunology.
[22] M. Radic,et al. Editors and editing of anti-DNA receptors. , 2001, Immunity.
[23] X. Mariette. Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells , 2001, Annals of the rheumatic diseases.
[24] G. Peltz,et al. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. , 2001, Immunity.
[25] A. Marx,et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. , 2001, Blood.
[26] Carl W. Miller,et al. Mutations in the mitotic check point gene, MAD1L1, in human cancers , 2001, Oncogene.
[27] E. Jaffe,et al. Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. , 2001, Blood.
[28] H. Doyle,et al. Lupus autoantigens: Their origins, forms, and presentation , 2001, Immunologic research.
[29] B. Haines,et al. Germline diversity of the expressed BALB/c VhJ558 gene family. , 2001, Molecular immunology.
[30] A. Carbone,et al. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. , 2000, Blood.
[31] R. Tibshirani,et al. The Inference of Antigen Selection on Ig Genes1 , 2000, The Journal of Immunology.
[32] M. Monestier,et al. Heavy Chain Revision in MRL Mice: A Potential Mechanism for the Development of Autoreactive B Cell Precursors1 , 2000, The Journal of Immunology.
[33] Ash A. Alizadeh,et al. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[34] J. D. Capra,et al. Receptor Revision of Immunoglobulin Heavy Chain Variable Region Genes in Normal Human B Lymphocytes , 2000, The Journal of experimental medicine.
[35] A. Soley,et al. Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells. , 2000, Arthritis and rheumatism.
[36] P. Gorevic,et al. Hepatitis C virus, autoimmunity and lymphoproliferation. , 2000, The Mount Sinai journal of medicine, New York.
[37] R. Tibshirani,et al. Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. , 2000, Blood.
[38] G. Prendergast,et al. Losses of the tumor suppressor BIN1 in breast carcinoma are frequent and reflect deficits in programmed cell death capacity , 2000, International journal of cancer.
[39] H. Morse,et al. Accelerated Appearance of Multiple B Cell Lymphoma Types in NFS/N Mice Congenic for Ecotropic Murine Leukemia Viruses , 2000, Laboratory Investigation.
[40] D. Sansonno,et al. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy. , 2000, Seminars in liver disease.
[41] S. Litwin,et al. Somatic Mutation and Light Chain Rearrangement Generate Autoimmunity in Anti–Single-Stranded DNA Transgenic Mrl/lpr Mice , 1999, The Journal of experimental medicine.
[42] Wei Du,et al. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms , 1999, Oncogene.
[43] C. Sokol,et al. MRL-lpr/lpr Mice Exhibit a Defect in Maintaining Developmental Arrest and Follicular Exclusion of Anti–double-stranded DNA B Cells , 1999, The Journal of experimental medicine.
[44] P. Casali,et al. Clonal evolution of B cells in transformation from low‐ to high‐grade lymphoma , 1999, European journal of immunology.
[45] P. Dejong,et al. The imprinted domain in mouse distal Chromosome 7: reagents for mutagenesis and sequencing , 1999, Mammalian Genome.
[46] M. Casado,et al. Lymphoma of the gastrointestinal tract , 1998 .
[47] T. Giese,et al. Spontaneous Development of Plasmacytoid Tumors in Mice with Defective Fas–Fas Ligand Interactions , 1998, The Journal of experimental medicine.
[48] E. Whitcomb,et al. Rearrangement and selection in the developing Vkappa repertoire of the mouse: an analysis of the usage of two Vkappa gene segments. , 1998, Journal of immunology.
[49] F. E. Bertrand,et al. Molecular mechanisms involved in receptor editing at the Ig heavy chain locus. , 1998, International immunology.
[50] M. J. Moreno Casado,et al. [Lymphoma of the gastrointestinal tract]. , 1998, Sangre.
[51] K. Rajewsky,et al. Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression , 1997, European journal of immunology.
[52] L. Duret,et al. Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle , 1997, Leukemia.
[53] L. Herzenberg,et al. An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. , 1997, Journal of immunology.
[54] T. Marion,et al. Correlation between the amino acid position of arginine in VH-CDR3 and specificity for native DNA among autoimmune antibodies. , 1996, Journal of immunology.
[55] A. Hayday,et al. A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice , 1996, The Journal of experimental medicine.
[56] Stanley N Cohen,et al. tsg101: A Novel Tumor Susceptibility Gene Isolated by Controlled Homozygous Functional Knockout of Allelic Loci in Mammalian Cells , 1996, Cell.
[57] T. Waldschmidt,et al. Phenotypic abnormalities of splenic and bone marrow B cells in lpr and gld mice. , 1996, Clinical immunology and immunopathology.
[58] E. L. Prak,et al. Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. , 1995, Immunity.
[59] J. Taylor,et al. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[60] D. Scadden,et al. Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma. , 1995, Blood.
[61] Wen-Hsiung Li,et al. Alternative mRNA Splicing and Differential Promoter Utilization Determine Tissue-specific Expression of the Apolipoprotein B mRNA-editing Protein (Apobec1) Gene in Mice. , 1995, The Journal of Biological Chemistry.
[62] B. Klein,et al. Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells. , 1995, Blood.
[63] M. Radic,et al. Genetic and structural evidence for antigen selection of anti-DNA antibodies. , 1994, Annual review of immunology.
[64] J Erikson,et al. B lymphocytes may escape tolerance by revising their antigen receptors , 1993, The Journal of experimental medicine.
[65] D. Tillman,et al. Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice , 1992, The Journal of experimental medicine.
[66] D. Bahler,et al. Clonal evolution of a follicular lymphoma: evidence for antigen selection. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[67] M. Hibi,et al. Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. , 1992, Journal of immunology.
[68] S. Kalled,et al. Utilization of V kappa families and V kappa exons. Implications for the available B cell repertoire. , 1991, Journal of immunology.
[69] L. Deaven,et al. A retinoic acid-responsive human zinc finger gene, MZF-1, preferentially expressed in myeloid cells. , 1991, The Journal of biological chemistry.
[70] R. Eisenberg,et al. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. , 1991, Annual review of immunology.
[71] P. Isaacson,et al. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. , 1988, Human pathology.
[72] P. Isaacson,et al. Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis. , 1988, Human pathology.
[73] D. Pisetsky,et al. Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[74] R. Riblet,et al. The immunoglobulin heavy chain variable region (Igh‐V) locus in the mouse. I. One hundred Igh‐V genes comprise seven families of homologous genes , 1984, European journal of immunology.
[75] R. Balderas,et al. Monoclonal IgM rheumatoid factors derived from arthritic MRL/Mp-lpr/lpr mice , 1983, The Journal of experimental medicine.